Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Oct 2026 for Recursion Pharmaceuticals, INC., €216k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Borgeson Blake: trading record in brief
Borgeson Blake discloses dealings in Recursion Pharmaceuticals, Inc. to SEC (Form 4). In total, 4 filings cover trades dated from 2 June 2026 to 6 October 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 6 October 2026: a transaction of €216k, in Recursion Pharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Borgeson Blake
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
50,000 shares@ US$4.84Class ASEC144:0001959173-26-007282
30,000 shares@ US$3.250.0048% mcap1.0% of flowClass ASEC144:0001959173-26-005593
40,000 shares@ US$3.96250.0079% mcap1.7% of flowClass ASEC144:0001959173-26-005138
30,000 shares@ US$3.680.0057% mcap1.1% of flowClass ASEC144:0001959173-26-004239
4 of 4 declarations
